The GECo team are really excited to announce that our first results will be presented at American Thoracic Society (ATS) #ATS2021 on 18th May by Trishul Siddharthan MD. We *can’t wait*!

It’s a big day for the GECo team as Trishul Siddharthan MD presents the top line results from GECo1, our LMIC #COPD screening study at #ATS2021 - session C005 0800am EDT. See you there!

It’s great to see our first Global Alliance for Chronic Diseases (GACD) Medical Research Council GECo results being presented right now at American Thoracic Society (ATS) #ATS2021. Abstract⬇️. But, in truth, our hearts and thoughts are with friends and colleagues affected by #COVID19 at our field sites in Nepal, Peru and Uganda. 🇳🇵🇵🇪 🇺🇬

Latest from the GECo team:

This fantastic piece of mixed-methods research in The Lancet Global Health by the FRESHAIRTeam really emphasises the need to understand local context when designing and implementing interventions to target chronic respiratory disease in LMIC settings. 👀 ⬇️ thelancet.com/journals/langl…

Watch this space… the results of our GECo1 study will be published this week..!

Did you catch the editorial by Drs Yawn, Leidy and Martinez that accompanied our article… worth a read… Screening for Chronic Obstructive Pulmonary Disease ja.ma/3fjHAaF via JAMA part of JAMA Network

The results of our Medical Research Council #COPD screening study found a prevalence of 18% in Bhaktapur, Nepal, and that simple tests identify a high-burden of important disease. Thanks to our incredible🇳🇵field team. Research led from UCL by John Hurst. JAMA 👀jamanetwork.com/journals/jama/…

In Lima 🇵🇪 our work was led by Oscar Flores-Flores 🇵🇪 and J. Jaime Miranda in collaboration with CRONICAS and Prisma ONG. The prevalence of #COPD here was 3% and screening tool accuracy was 72-91%. You can read more in the current issue of JAMA. Here is our awesome field team🔽

Our 🇺🇬 site was expertly run from Makerere University Lung Institute by Bruce Kirenga and Patricia Alupo. The prevalence of #COPD in rural Nakaseke was 7% and screening test accuracy was 76-82%. Only 12% GOLD COPD ‘A’. 17% ever smoked. More in our JAMA paper: jamanetwork.com/journals/jama/…

"The high prevalence of clinically significant disease was surprising & emphasises the need for a greater focus on chronic respiratory disease": John Hurst UCL Faculty of Medical Sciences on his global GECo study evaluating screening tools for #COPD. In Reuters Health mdalert.com/news/article/s…

⚠️NEW data from the GECo team now on line ATS Blue Journal: “Cost-Accuracy Analysis of COPD Screening in Low- and Middle-Income Countries” | AJRCCM | Articles in Press atsjournals.org/doi/abs/10.116…

The GECo team were thrilled to see our paper selected as ‘top five’ in the #ATS2022 COPD Clinical Year in Review. Great recognition for our teams in 🇳🇵 🇵🇪 🇺🇬.

On behalf of the whole team, I’m privileged to be presenting our GECo results today at the ERS #ERS2022 JAMA Symposium. Thread and link to paper below, or Hall 8B 930 CET and live streamed.

This IQ&A answer provides an overview of the prevalence of long COVID and the most common symptoms in the general population. It also describes special considerations for Asthma and COPD patients. buff.ly/36G6kcx @atscommun Global Initiative for Asthma (GINA) American Thoracic Society (ATS) #@GOLD_COPD GECo

It's a big day for the GECo team here American Thoracic Society (ATS) #ATS2023 as Will Checkley presents the results of GECo2: our RCT of Community-Health Worker supported self-management for symptomatic #COPD across three LMIC settings in🇳🇵🇵🇪🇺🇬.

👀🆕 Which interventions for #COPD have the greatest unmet need in low- and middle income country settings? Read more in our latest Medical Research Council funded Global Alliance for Chronic Diseases (GACD) work, the GECo study, now online ATS Blue Journal: pubmed.ncbi.nlm.nih.gov/37369142/

Great to see the ATS Blue Journal special issue on #COPD out today, link below, and I’m super proud to be part of collaborations on two articles: unmet needs in LMIC setting from GECo, and a viewpoint on respiratory health in cities. atsjournals.org/toc/ajrccm/cur…

It’s out!!!! Thank you to all our investigators, collaborators, field teams, supporters, participants and funders! A thread from John Hurst explains the results….